Plain-English translation of NCT07427498 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some people with Parkinson's disease experience visual hallucinations while others don't. This study asks participants to complete simple visual perception tasks—like reporting whether they see something that may or may not actually be there—while researchers measure how expectations influence these decisions. By comparing people with Parkinson's who have hallucinations, those without hallucinations, and healthy volunteers, the study aims to uncover the brain mechanisms behind false perceptions.
Visual hallucinations are a common and troubling symptom of Parkinson's disease that can significantly affect quality of life and caregiver burden. Current research suggests that hallucinations may happen when the brain relies too heavily on expectations rather than on what the senses actually detect, but this connection hasn't been directly studied in Parkinson's patients.
You likely qualify if…
You likely don't qualify if…
You would visit the research site to complete visual perception tasks, where you'll be shown images that may or may not contain a stimulus and report what you see. For some participants (those with certain types of Parkinson's treatment), researchers may also record brain activity from existing deep-brain stimulation electrodes to understand how the brain processes these visual decisions. The study involves three groups: people with Parkinson's who experience hallucinations, people with Parkinson's without hallucinations, and healthy volunteers for comparison.
AI-generated summary from trial data · Nov 14, 2026 · Not medical advice
France
Sponsor
University Hospital, Grenoble
Collaborators
INSERM U1216 Grenoble Institut des Neurosciences
Enrollment target
~60 participants
Started
April 2026
Primary completion
April 2028
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anna Castrioto, MD, PhD
University Hospital, Grenoble
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.